|
|
Administration Core |
| 1P01AG073090-01A1 |
|
NIA |
2022 |
|
|
Parenchymal border macrophages in AD and CAA |
| 1P01AG078106-01 |
|
NIA |
2022 |
|
|
Interplay between meningeal lymphatics, high-density lipoproteins and border macrophages in cerebral amyloid angiopathy |
| 1P01AG078106-01 |
|
NIA |
2022 |
|
|
Cerebral amyloid angiopathy: Role of ApoE, innate immunity, and meningeal lymphatics |
| 1P01AG078106-01 |
|
NIA |
2022 |
|
|
Project 3 - Astrocytic glutamate dysregulation in AD and VCID |
| 1P01AG078116-01 |
|
NIA |
2022 |
|
|
Project 2 - Astrocytic insulin signaling and AD |
| 1P01AG078116-01 |
|
NIA |
2022 |
|
|
A Randomized Trial of Gamification and Coaching to Improve Mobility after Hospitalization |
| 1R01AG071597-01A1 |
|
NIA |
2022 |
|
|
The Study of Muscle and Physical Performance in African Caribbeans. |
| 1R01AG074956-01 |
|
NIA |
2022 |
|
|
Impact of mitochondrial genetics on muscle oxidative capacity, fitness, and mobility in older adults |
| 1R01AG075081-01A1 |
|
NIA |
2022 |
|
|
Digital Markers of Mobility in Daily Life to Track Progression in Newly Diagnosed Parkinsons Disease |
| 1R01AG077380-01A1 |
|
NIA |
2022 |